心血管死亡率正在下降,但仍然是世界范围内死亡的主要原因。呼吸道感染如流感显著导致心血管疾病患者的发病率和死亡率。尽管有证明的好处,流感疫苗接种没有完全实施,尤其是在拉丁美洲。
目的是就流感疫苗接种和心血管疾病提出区域共识。
由美洲心血管疾病管理和预防专家组成的多学科团队,由美洲心脏病学会(IASC)和世界心脏联合会(WHF)召集,参与了过程和报表的制定。使用改良的RAND/UCLA方法。该文件得到了WHF的资助。
广泛的文献检索分为七个问题,共达成23项结论和29项建议。专家在结论或建议中没有分歧。
流感和心血管事件之间有很强的相关性。流感疫苗接种不仅是安全的,而且是减少心血管事件的有效策略,但也节约了成本。我们发现了其全球实施的几个障碍以及克服这些障碍的潜在战略。
Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly contribute to morbidity and mortality in patients with cardiovascular disease. Despite of proven benefits, influenza vaccination is not fully implemented, especially in Latin America.
The aim was to develop a regional
consensus with recommendations regarding influenza vaccination and cardiovascular disease.
A multidisciplinary team composed by experts in the management and prevention of cardiovascular disease from the Americas, convened by the Inter-American Society of Cardiology (IASC) and the World Heart Federation (WHF), participated in the process and the formulation of statements. The modified RAND/UCLA methodology was used. This document was supported by a grant from the WHF.
An extensive literature search was divided into seven questions, and a total of 23 conclusions and 29 recommendations were achieved. There was no disagreement among experts in the conclusions or recommendations.
There is a strong correlation between influenza and cardiovascular events. Influenza vaccination is not only safe and a proven strategy to reduce cardiovascular events, but it is also cost saving. We found several barriers for its global implementation and potential strategies to overcome them.